San Diego, CA, United States of America

Robert Davis

This inventor holds 10 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Intra-Cellular Therapies, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 10 

% Patents Active = 90.0

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Davis

Introduction

Robert Davis is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of disorders associated with dementia. With a total of 10 patents to his name, Davis continues to push the boundaries of medical innovation.

Latest Patents

Davis's latest patents include groundbreaking work on compounds and methods for treating dementia-related disorders. One of his inventions focuses on the use of substituted heterocycle fused gamma-carbolines, which can be utilized in various forms, including free, pharmaceutically acceptable salt or prodrug forms. This invention aims to address behavioral and mood disturbances, psychosis, depression, and sleep disturbances in dementia patients. Another significant patent involves methods of treatment using lumateperone mono-tosylate capsules. This patent details pharmaceutical capsules that comprise lumateperone, either in free or pharmaceutically acceptable salt form, and outlines processes for their manufacture and methods of use in disease treatment or prophylaxis.

Career Highlights

Davis is currently associated with Intra-Cellular Therapies, Inc., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing therapeutic options for patients suffering from complex neurological disorders.

Collaborations

Some of his notable coworkers include Lawrence P. Wennogle and Peng Li, who have collaborated with him on various projects aimed at enhancing treatment methodologies in the pharmaceutical sector.

Conclusion

Robert Davis exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of dementia treatment, highlight the importance of research and development in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…